Evaluation of Muscle Strength and Muscle Mass in Patients With Inflammatory Bowel Disease
Observational · No treatment assigned · 1 site · Sakarya University
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Crohn Disease (CD). This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- Age ≥18 years
- Established diagnosis of inflammatory bowel disease (ICD-10: K50.* Crohn's disease, K51.* ulcerative colitis)
- Ability to provide written informed consent
Plus 2 more requirement(s). There are also 6 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 100 participants are expected to take part.
- Start date: 2025-11-10.
- Main results expected around 2026-11-10 (estimate from the record).
- 1 study site listed (1 marked recruiting) in Turkey (Türkiye).
Main thing being measured
- Agreement Between Ultrasound and Reference Muscle Measurement (Baseline (at time of assessment))
In the researchers’ words
This prospective observational study aims to evaluate the validity of ultrasonographic muscle measurements in patients with inflammatory bowel disease (IBD). Sarcopenia is commonly assessed using computed tomography (CT)-based skeletal muscle area measurements at the L3 vertebral level, which are considered a gold standard method.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Crohn Disease (CD) |
| Lead sponsor | Sakarya University |
| Enrollment | 100 (estimated) |
| Start date | 2025-11-10 |
| Primary completion (est.) | 2026-11-10 |
| First posted | 2026-03-02 |
| Last updated | 2026-03-02 |
| Official title | Evaluation of Sarcopenia in Patients With Inflammatory Bowel Disease |
| ClinicalTrials.gov ID | NCT07441447 |
Interventions
- Muscle Ultrasonography (Diagnostic Test)
Standardized ultrasonographic measurement of skeletal muscle thickness and quality performed in patients with inflammatory bowel disease for comparison with reference muscle assessment methods.
Full eligibility criteria (from the record)
Inclusion Criteria: * Age ≥18 years * Established diagnosis of inflammatory bowel disease (ICD-10: K50.* Crohn's disease, K51.* ulcerative colitis) * Ability to provide written informed consent * Ability to undergo ultrasonographic muscle assessment and handgrip strength testing * Availability of an abdominal computed tomography (CT) scan performed within the previous 6 months Exclusion Criteria: * Known neuromuscular disorders or primary muscle diseases * Major orthopedic conditions affecting muscle strength assessment * Pregnancy * Abdominal wall defects or conditions interfering with ultrasound assessment * Incomplete clinical or imaging data * Any condition preventing reliable ultrasound or handgrip measurement
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Sakarya University Faculty of Medicine, Training and Research Hospital | Sakarya, Adapazarı | Turkey (Türkiye) | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.